CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Therapeutic hypothermia +4 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02849561
NCT02849561N/ACompleted

Evaluation of Prognosis Factors of Neurological Evolution in Cardiac Arrest : Prospective Study of Routine Care

University Hospital, Grenoble·interventional·Posted Jul 29, 2016·Updated Jul 29, 2016

In Brief

A clinical study evaluating Therapeutic hypothermia, Synchronized Intermittent Mandatory Ventilation, and 3 other interventions for Cardio Respiratory Arrest. Completed, enrolled 82 participants across 1 site.

Detailed Summary

With the repercussion of 55 cases eachyear for 100 000 inhabitants in France, cardio respiratory arrest is a public health issue. The goal of this study is to evaluate the pupillary light reflex measured by the dimension of the pupil (diameter) as a prognosis factor neurological evolution in post cardiac arrest. By participating to this study, the patient get the same tratments and exams than in a usual managing cares. In addition of these events, the pupillary light reflex is studied as soon as the patient is accepted in the department, and then on the second day. Currently, the evaluation of the neurological becoming rely on a multimodal clinical and paraclinical approach. The study of the pupillary light reflex measured by the diameter of the pupil could be a prognosis factor of neurological evolution for patients in post cardiac arrest, so a reliable and available prognosis marker in patient care. The goal of this study is to evaluate the pupillary light reflex (RPM), measured by the diameter of the pupil as a prognosis factor of neurological evaluation of admitted patients after a cardiac arrest. Principal criteria of judgement is the percentage of the pupillary light reflex variation measured with Neurolight®, compared between two groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 29, 2016
Enrollment StartJan 1, 2014
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.9 years ago

Interventions

Therapeutic hypothermiaother

With a mattress at 4°C to reach a central temperature at 33,5°C.

Synchronized Intermittent Mandatory Ventilationdevice

Constant volume 6 ml/kg

Electroencephalographyother

Pupillary light reflex surveillancedevice

With Neurolight® device.

Transcranial Dopplerdevice

Monitoring tool for brain hemodynamic evaluation. With Philips HD15 Ultrasound system®.